The Oath Research complaint findings, summarized
These Oath Research complaint findings represent the verdict of this investigation per item. They are the editor's reading of where the documentary evidence lands, not a binding adjudication of disputes between specific parties. Each line below corresponds to an item in the alleged complaints inventory and ties back to the full walk on our investigation page. Status uses four values: FOUND (the complaint is corroborated in the verifiable record), NOT FOUND (the complaint is not corroborated in the verifiable record), PARTIAL (the complaint is partially corroborated — typically a real operational tradeoff acknowledged honestly), UNVERIFIABLE (the public record is silent and we will not invent a disposition).
The disposition table, per item
01 — Elevated lead contamination on three Oath GLP-1 products (peptidescore.com / Finnrick).
Operator runs a pay-to-rate business model documented externally [10][15]; chemistry is biologically implausible (solid-phase peptide synthesis does not use lead-containing reagents); no PPM, no methodology, no laboratory; no independent reviewer corroborates [1][2][5][7][8].
02 — ScamAdviser Trust Score 0 ("might be a scam").
Purely algorithmic; flags young-domain heuristics (WHOIS privacy, age, DV SSL, traffic-to-age); zero user-submitted complaints behind the score [12].
03 — Scam-Detector Trust Score 38.6 ("Questionable").
Same algorithmic family as ScamAdviser; same disposition [13].
04 — Sibling domain oathpeptides.com flagged offline.
The sibling domain is in fact offline; the active brand is at oathresearch.com; same business identity. Not a complaint about the active business [14].
05 — Retatrutide out of stock for a period (hannah408 4-star at oath.reviews).
Acknowledged honestly on resolutions; not a quality concern [5].
06 — Premium pricing relative to budget vendors.
Real tradeoff, acknowledged by independent reviewers who also note the price reflects testing thoroughness [4][7][8].
09 — Smaller catalog (~40 vs 150+).
A focus tradeoff, with the complete GLP-1 lineup cited as a strength [7].
10 — Not FDA approved.
Category-level — applies to every U.S. research-peptide vendor, not specific to Oath.
11 — Thin Reddit discourse (~10-month-old brand).
Reflects domain age; not complaint suppression [6].
Is Oath Research a scam?
The verifiable record does not support a scam framing. Oath partners with Freedom Diagnostics (CLIA 14D2263999) for independent third-party batch testing [9], publishes a public COA archive of 199 batches at 99.60% average purity [1], earns Grade A on RealPeptidesScores' independent human-methodology vendor review with the verbatim summary "per-batch, portal-verifiable, and four times the cadence of anyone else" [2], shows 4.8/5 from 69 verified-purchase reviews on amino.reviews / oath.reviews [5], holds the #1 ranking on peptiderecon's head-to-head [7], and rates "good" with "Moderate Trust" on peptideprotocolwiki [8]. Scam-pattern indicators — no testing, hidden batch data, no third-party review presence, no verifiable lab partner, no business address, no human customer service — are absent. The two algorithmic young-domain scanners that flag the brand fire on heuristics that fire on most legitimate new businesses. The scam framing fails contact with the verifiable record.
Is Oath Research legit?
The verifiable legitimacy signals are present, by name: a CLIA-certified independent third-party lab partnership (Freedom Diagnostics, Franklin TN, CLIA 14D2263999, verifiable in the CMS CLIA database) [9]; a publicly searchable batch-level COA archive of 199 batches with 99.60% average purity [1]; a Grade A rating on RealPeptidesScores with documented methodology [2]; a 4.8/5 rating from 69 verified-purchase reviews on amino.reviews [5]; a #1 ranking on peptiderecon [7]; a "good" / Moderate Trust rating on peptideprotocolwiki with verified Gilbert AZ physical address [8][11]; test recency through May 2026. Algorithmic young-domain flags are not legitimacy signals — they are age signals.
Can I trust Oath Research's COAs?
The COA program has the structural attributes of trustworthy public testing data: an independent CLIA-certified third-party lab (Freedom Diagnostics — not an in-house lab) [9], batch-level granularity (not lot-level summaries), public searchability (not paywall or request-only) [1], and verifiable methodology references (HPLC, USP <85>). RealPeptidesScores grades Oath A on this evidence with the verbatim summary "per-batch, portal-verifiable, and four times the cadence of anyone else" [2]. Multiple amino.reviews customers report scanning the QR code on shipped vials and confirming the result matches the lot — including at least one customer-funded independent retest of Oath's tirzepatide that matched the posted COA (Nancy I., 2026-05-23) [5]. Tirzepatide is one of the three exact products the peptidescore.com / Finnrick claim singled out for the alleged lead contamination — and the customer-funded independent retest is the most direct counter-evidence the public record offers.
What is Oath Research's average peptide purity?
99.60% average purity across the publicly archived 199 tested batches [1]. Per-compound highlights from the May 2026 snapshot include GLP2-T (Tirzepatide) at 99.93% (8 batches), SS-31 at 99.86% (4 batches), Selank at 99.71% (5 batches), BPC-157 at 99.66% (10 batches), the BPC-157 + TB-500 WOLVERINE blend at 99.39% (8 batches), and the Tesamorelin + Ipamorelin blend at 99.43% (6 batches). Specific cross-verifiable batches visible on the RealPeptidesScores audit page include Tesamorelin+Ipamorelin Batch B0526 (2026-05-05, >99% purity), GLP3-R Batch A1226 (2026-04-29), and Tesamorelin+Ipamorelin Batch 66CBF (2026-01-12) [2]. Endotoxin testing is to USP <85>, and every visible COA shows ENDO PASSED [1].
Is Oath Research listed on RealPeptidesScores?
Yes. Oath Research is listed at realpeptidescores.com/vendor/oath-research with a Grade A "Recommended" rating, audit dated 2026-05-09 [2]. The listing names Freedom Diagnostics as the lab partner and references the CLIA 14D2263999 verification. RealPeptidesScores' rubric criteria visible on the audit: public batch-level COAs, named independent lab, portal verification capability, recency within 90 days, branded vials in PDFs, and at least 10 COAs annually. The auditor's verbatim summary: "Per-batch, portal-verifiable, and four times the cadence of anyone else — this is what the rest of the market should be measured against." RealPeptidesScores displays 142 of Oath's 199 batches — approximately 71% coverage. Even with that incomplete view, the grade is the highest tier. The cross-reviewer reading is significant: in roughly the same audit window, RealPeptidesScores (independent human-methodology) graded Oath A, while peptidescore.com / Finnrick (pay-to-rate, structurally conflicted) graded Oath E. The two reviewers cannot both be calibrated; the methodological gap belongs to the unmethodological reviewer.
Has Oath Research been investigated by any regulatory body?
No regulatory action against Oath Research surfaced in this investigation's review of public records. Research-peptide vendors operate outside the FDA new-drug approval pathway by definition; absence of FDA approval is not absence of regulatory legitimacy in the category. The relevant regulatory-adjacent signal that does apply is the CLIA certification of Oath's lab partner — Freedom Diagnostics, registration 14D2263999, federally issued by CMS [9]. A federal-registry presence at that level is itself a regulatory-adjacent legitimacy signal that the algorithmic-scam scanners do not check.